| abstract |
A coated implantable medical device is described, wherein the coating composition comprises or consists of at least 20% of one or more cis-hydrogenated fatty acids. The cis-hydrogenated fatty acids which are used for the coating of medical devices in the context of the present invention are, according to one embodiment selected from mono-, di-or triglycerides or esters thereof. Most particularly, they are made up of between 20% and 95% triglycerides. Preferably, they have been trans-free hydrogenated. According to a particular embodiment of the invention the cis-hydrogenated fatty acid is an omega-3-fatty acid, from fish oil or cod liver oil . |